RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
Brain Cancer - Pipeline Review, Q3 2011
Jul 2011 - 327 pages - $500
Glioblastoma Multiforme - Pipeline Review, Q1 2011
Jan 2011 - 112 pages - $500
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
ZIOPHARM Oncology Inc: Corporate and Strategic Assessment Report – Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile
Jun 2008 - 40 pages - $495
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Metastatic Brain Tumors Global Clinical Trials Review, Q4, 2010
Dec 2010 - 44 pages - $1,000
Molecular Targeted Cancer Therapies Market Forecast
Aug 2009 - $15,200
Brain Cancer Global Clinical Trials Review, H2, 2011
Aug 2011 - 120 pages - $1,000
Glioblastoma Multiforme (GBM) - Pipeline Review, Q3 2011
Jul 2011 - 135 pages - $500
More Related Market Research Reports >>>

Your selection

Therapeutic target
Oncology del
Brain cancer del
Glioblastoma del
Year
2002 del

Browse By

Industry sector
Academic/Research
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Non-profit org./Government
Pharmaceutical
Research tools
Service

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us